amikacin has been researched along with linezolid in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (16.95) | 29.6817 |
2010's | 26 (44.07) | 24.3611 |
2020's | 23 (38.98) | 2.80 |
Authors | Studies |
---|---|
Bouza, E; Cercenado, E; Cuevas, O; Marín, M; Martínez-Alarcón, J; Sánchez-Martínez, M | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brönstrup, M; Dogonadze, M; Kantin, G; Karge, B; Krasavin, M; Manicheva, O; Parchinsky, V; Vinogradova, T | 1 |
Mabhula, A; Singh, V | 1 |
Escalante-Fuentes, WG; Gómez-Flores, A; Vera-Cabrera, L; Welsh, O | 1 |
Lam, CS; Lee, HK; Leung, KT; Ng, HL; Siu, YP; Tong, MK | 1 |
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J; Truffot, C | 1 |
Jackson, MA; Selvarangan, R; Sharma, M; Thorell, EA; Woods, GM | 1 |
Alvarez Tundidor, S; González Rozas, M; Pineda Alonso, M | 1 |
Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M | 1 |
Borole, AJ; Chilgar, RM; D'Silva, JA; Thomas, M | 1 |
Bulitta, JB; Landersdorfer, CB; Ly, NS; Tsuji, BT; Xu, H | 1 |
Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
Fisher, MA; Hanson, KE; Schlaberg, R | 1 |
Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M | 1 |
Blackmore, T; McNaughton, A; McNaughton, H | 1 |
Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N | 1 |
Carrasco, G; Garrido, N; Medina-Pascual, MJ; Navarro, AM; Saéz-Nieto, JA; Valdezate, S; Villalón, P | 1 |
Lu, J; Pang, Y; Song, Y; Zhang, Z | 1 |
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
Akkerman, OW; Bathoorn, E; de Lange, WCM; Lokate, M; Louka, C; Pournaras, S; Ravensbergen, SJ; Stienstra, Y; van der Werf, TS | 1 |
Barkan, D; Grosfeld, T; Meir, M | 1 |
Decousser, JW; Dowzicky, MJ; Fines-Guyon, M; Soussy, CJ; Woerther, PL | 1 |
Bergeron, E; Berthet, J; Boiron, P; Djadi-Prat, J; Lebeaux, D; Lortholary, O; Mouniée, D; Rodriguez-Nava, V | 1 |
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M | 1 |
Farooqui, F; Irfan, S; Shakoor, S; Zafar, A | 1 |
Laughon, BE; Lee, SFK; Lipman, M; McHugh, TD | 1 |
Bostan, C; Boutin, T; Brunette, I; Choremis, J; Mabon, M; Slim, E; Talajic, JC | 1 |
Alagna, R; Besozzi, G; Castellotti, P; Cirillo, D; Codecasa, L; De Lorenzo, S; Ferrarese, M; Mazzola, E; Riccardi, N; Saderi, L; Sotgiu, G; Udwadia, Z; Viggiani, P | 1 |
Ardanuy, C; Càmara, J; Cilloniz, C; Ercibengoa, M; Galar, A; García-Olivé, I; García-Somoza, D; Marimón, JM; Marin, M; Martín-Rabadán, P; Mateu, L; Muñoz, P; Pedro-Botet, ML; Prat, C; Torres, A; Tubau, F | 1 |
Abu Saleh, OM; Deml, SM; Fida, M; Hamdi, AM; Wengenack, NL | 1 |
Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y | 1 |
Dash, A; Gupta, N; Kodan, P; Ray, Y; Singh, BK; Soneja, M | 1 |
Basdeo, SA; Cahill, C; Cox, DJ; Gogan, KM; Gordon, SV; Keane, J; O'Connell, F; O'Sullivan, J; Phelan, JJ | 1 |
Bartolomeo, K; Hassanein, M; Vachharajani, TJ | 1 |
Arai, Y; Iguchi, S; Kamada, K; Kikuchi, K; Konno, S; Shimojima, M; Uzawa, Y; Yoshida, A | 1 |
Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B | 1 |
Chen, CH; Chen, NY; Chiu, CH; Chung, WH; Lai, HC; Lao, CK; Lee, CH; Liu, TP; Lu, JJ; Tseng, MC; Wu, TS; Yang, LY | 1 |
Bond, K; Globan, M; Lea, K; Naimo, P; Williamson, DA; Yeoh, K | 1 |
De Vito, D; Fruscio, G; Garrisi, VM; Hall, GG; Laforgia, M; Nardulli, P; Quarta, A; Ruggiero, R; Scacco, S | 1 |
Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A | 1 |
Habib, A; Qadir, A | 1 |
Chen, FJ; Kuo, SF; Lee, CH; Yang, CH | 1 |
Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y | 1 |
Alcaide, F; Andres, S; Aubry, A; Benmansour, H; Boarbi, S; Cambau, E; Chryssanthou, E; Cirillo, DM; Fernström, L; Fitzgibbon, MM; Fröberg, G; Giske, CG; Hyyryläinen, HL; Kahlmeter, G; Keller, PM; Machado, D; Maurer, FP; Mengshoel, AT; Mok, S; Nadarajan, D; Schön, T; Svensson, E; Turnidge, J; van Ingen, J; Viveiros, M; Werngren, J | 1 |
Asa'ad, S; Castagliuolo, I; Cordioli, G; De Canale, E; Del Vecchio, C; Di Pietra, G; Meneghello, S | 1 |
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
McKinney, WP; Morris, AJ; Roberts, SA; Smith, MR | 1 |
Liao, X; Long, S; Pan, J; Shi, G; Sun, Q; Wang, C; Wang, G; Yan, J; Yang, X; Zhang, Y; Zhao, Y; Zheng, M | 1 |
Adeel, A; Ahmad, A; Ahmad, I; Aslam, H; Mushtaq, F; Raza, SM; Saleem, S | 1 |
Faksri, K; Hinwan, Y; Kaewprasert, O; Sirichoat, A | 1 |
7 review(s) available for amikacin and linezolid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-resistance in
Topics: | 2019 |
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.
Topics: Amikacin; Anti-Bacterial Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nitroimidazoles; Oxazoles | 2019 |
Management of peritoneal dialysis
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Humans; Linezolid; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis; Peritonitis | 2022 |
Nocardia infections in Italy: from a local to a national view.
Topics: Aged; Amikacin; Anti-Infective Agents; Female; Humans; Italy; Linezolid; Male; Middle Aged; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
The species distribution and antimicrobial resistance profiles of Nocardia species in China: A systematic review and meta-analysis.
Topics: Amikacin; Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
1 trial(s) available for amikacin and linezolid
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
51 other study(ies) available for amikacin and linezolid
Article | Year |
---|---|
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
New nitrofurans amenable by isocyanide multicomponent chemistry are active against multidrug-resistant and poly-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cyanides; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Proton Magnetic Resonance Spectroscopy | 2017 |
In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.
Topics: Acetamides; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Dermatomycoses; Drug Therapy, Combination; Humans; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Oxazolidinones; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid.
Topics: Acetamides; Amikacin; Anti-Infective Agents; Aortic Valve; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2004 |
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans.
Topics: Acetamides; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Diarylquinolines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Foot; In Vitro Techniques; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Nitroimidazoles; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Survival Analysis; Time Factors | 2006 |
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Linezolid; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections; Oxazolidinones; Treatment Outcome | 2006 |
Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Drug Therapy, Combination; Humans; Hypokalemia; Linezolid; Lung Diseases, Fungal; Male; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Potassium Chloride; Pyrimidines; Triazoles; Voriconazole | 2011 |
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin | 2011 |
Periprosthetic atypical mycobacterial infection in breast implants: a new kid on the block!
Topics: Acetamides; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Breast Implants; Clarithromycin; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mammaplasty; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Reoperation | 2013 |
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design.
Topics: Acetamides; Amikacin; Colony Count, Microbial; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Statistical; Nisin; Oxazolidinones | 2013 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Susceptibility profiles of Nocardia isolates based on current taxonomy.
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Oxazolidinones; Phylogeny; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin | 2015 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline | 2017 |
Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Prevalence; RNA, Ribosomal, 16S; Spain; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; DNA-Directed RNA Polymerases; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2018 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.
Topics: Adult; Amikacin; Carbapenem-Resistant Enterobacteriaceae; Clofazimine; Drug Monitoring; Humans; Linezolid; Male; Moxifloxacin; Netherlands; Prevalence; Prothionamide; Refugees; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Multidrug-Resistant | 2018 |
Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.
Topics: Amikacin; Animals; Larva; Levofloxacin; Linezolid; Meropenem; Moths; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2018 |
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Levofloxacin; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus pneumoniae; Tigecycline; Vancomycin | 2018 |
Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Disk Diffusion Antimicrobial Tests; Female; France; Humans; Imipenem; Linezolid; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; Retrospective Studies; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2019 |
Antimicrobial susceptibility and clinical characteristics of Nocardia isolates from a tertiary care centre diagnostic laboratory in Pakistan.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Pakistan; Tertiary Care Centers; Young Adult | 2018 |
Successful management of severe post-LASIK Mycobacterium abscessus keratitis with topical amikacin and linezolid, flap ablation, and topical corticosteroids.
Topics: Ablation Techniques; Administration, Topical; Adult; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Keratitis; Keratomileusis, Laser In Situ; Linezolid; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Surgical Flaps; Surgical Wound Infection | 2019 |
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres.
Topics: Adult; Amikacin; Antitubercular Agents; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Italy; Laboratories, Hospital; Linezolid; Male; Meropenem; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
A multicentre analysis of Nocardia pneumonia in Spain: 2010-2016.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Middle Aged; Nocardia; Nocardia Infections; Pneumonia, Bacterial; Retrospective Studies; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2020 |
Retrospective Analysis of Antimicrobial Susceptibility Profiles of
Topics: Aged; Amikacin; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Laboratories; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minnesota; Nocardia; Nocardia Infections; Retrospective Studies; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex.
Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA | 2020 |
Choosing the therapy for neurological infection with rapidly growing mycobacteria.
Topics: Administration, Intravenous; Adolescent; Amikacin; Central Nervous System Bacterial Infections; Clinical Decision-Making; Female; Humans; Imipenem; Levofloxacin; Linezolid; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ventriculoperitoneal Shunt | 2020 |
The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG.
Topics: Amikacin; Antitubercular Agents; Bacterial Load; Cell Survival; Clofazimine; Cycloserine; Deferoxamine; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Gene Expression; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Iron; Iron Chelating Agents; Linezolid; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium bovis; Primary Cell Culture; Pyrazinamide | 2021 |
Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Japan; Linezolid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2021 |
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin | 2022 |
Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Humans; Imipenem; Immunosuppressive Agents; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Taiwan; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Identification and antimicrobial susceptibility of referred
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Victoria | 2022 |
Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2022 |
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosfamide; Imipenem; Linezolid; Microbial Sensitivity Tests; Mycetoma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
Clinical manifestations and outcome of nocardiosis and antimicrobial susceptibility of Nocardia species in southern Taiwan, 2011-2021.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Linezolid; Nocardia; Nocardia Infections; Retrospective Studies; RNA, Ribosomal, 16S; Taiwan; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin | 2023 |
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria | 2023 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
Species distribution and susceptibility of Nocardia isolates in New Zealand 2002-2021.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Linezolid; Microbial Sensitivity Tests; New Zealand; Nocardia; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
Topics: Amikacin; Antitubercular Agents; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Verapamil | 2023 |
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phylogeny; Thailand | 2023 |